Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia

Transfusion

Volumn 47, Issue 5, 2007, Pages 901-910

  Ghevaert, Cedric ^a   Campbell, Kate ^b   Walton, Jill ^b   Smith, Graham A ^b   Allen, Dave ^b   Williamson, Lorna M ^b   Ouwehand, Willem H ^b   Ranasinghe, Edmund ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BRAIN HEMORRHAGE; CHILD DEATH; CHORIOAMNIONITIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FETOMATERNAL ALLOIMMUNE THROMBOCYTOPENIA; FETUS DEATH; FOLLOW UP; HUMAN; IMMUNIZATION; INTRAUTERINE BLOOD TRANSFUSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MOTHER FETUS RELATIONSHIP; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PERINATAL PERIOD; PRENATAL PERIOD; PROSPECTIVE STUDY; RANDOMIZATION; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; BLOOD TRANSFUSION, INTRAUTERINE; FEMALE; FETAL BLOOD; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT, NEWBORN; ISOANTIBODIES; ISOANTIGENS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 34247626503     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01208.x     Document Type: Article

References (41)

1. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993 329 : 1463 6.
2. Metcalfe P, Watkins NA, Ouwehand WH, et al. Nomenclature of human platelet antigens. Vox Sang 2003 85 : 240 5.
3. Mueller-Eckhardt C, Kiefel V, Grubert A, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989 1 : 363 6.
4. Davoren A, Curtis BR, Aster RH, et al. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004 44 : 1220 5.
5. Williamson LM, Hackett G, Rennie J, et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998 92 : 2280 7.
6. Jaegtvik S, Husebekk A, Aune B, et al. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies: the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn. BJOG 2000 107 : 691 4.
7. Durand-Zaleski I, Schlegel N, Blum-Boisgard C, et al. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. Am J Perinatol 1996 13 : 423 31.
8. Dreyfus M, Kaplan C, Verdy E, et al. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood 1997 89 : 4402 6.
9. Turner ML, Bessos H, Fagge T, et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005 45 : 1945 56.
10. Giovangrandi Y, Daffos F, Kaplan C, et al. Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia. Lancet 1990 336 : 310.
11. Murphy MF, Waters AH, Doughty HA, et al. Antenatal management of fetomaternal alloimmune thrombocytopenia - report of 15 affected pregnancies. Transfus Med 1994 4 : 281 92.
12. Berry JE, Murphy CM, Smith GA, et al. Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens. Br J Haematol 2000 110 : 735 42.
13. Mandelbaum M, Koren D, Eichelberger B, et al. Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization. Vox Sang 2005 89 : 39 43.
14. Ouwehand WH, Smith G, Ranasinghe E. Management of severe alloimmune thrombocytopenia in the newborn. Arch Dis Child Fetal Neonatal Ed 2000 82 : F173 F175.
15. Gibson BE, Todd A, Roberts I, et al. Transfusion guidelines for neonates and older children. Br J Haematol 2004 124 : 433 53.
16. Garner SF, Smethurst PA, Merieux Y, et al. A rapid one-stage whole-blood HPA-1a phenotyping assay using a recombinant monoclonal IgG1 anti-HPA-1a. Br J Haematol 2000 108 : 440 7.
17. Bugert P, McBride S, Smith G, et al. Microarray-based genotyping for blood groups: comparison of gene array and 5′-nuclease assay techniques with human platelet antigen as a model. Transfusion 2005 45 : 654 9.
18. Kiefel V. The MAIPA assay and its applications in immunohaematology. Transfus Med 1992 2 : 181 8.
19. Ranasinghe E, Walton JD, Hurd CM, et al. Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia. Br J Haematol 2001 113 : 40 2.
20. Allen DL, Samol J, Benjamin S, et al. Survey of the use and clinical effectiveness of HPA-1a/5b-negative platelet concentrates in proven or suspected platelet alloimmunization. Transfus Med 2004 14 : 409 17.
21. Holensteiner A, Walchshofer S, Adler A, et al. Human platelet antigen gene frequencies in the Austrian population. Haemostasis 1995 25 : 133 6.
22. Sellers J, Thompson J, Guttridge MG, et al. Human platelet antigens: typing by PCR using sequence-specific primers and their distribution in blood donors resident in Wales. Eur J Immunogenet 1999 26 : 393 7.
23. Merieux Y, Debost M, Bernaud J, et al. Human platelet antigen frequencies of platelet donors in the French population determined by polymerase chain reaction with sequence-specific primers. Pathol Biol (Paris) 1997 45 : 697 700.
24. Austin EB, Smith LC, Walker RY. An anti-idiotopic antibody-based enzyme-linked immunosorbent assay for the quantification of the monoclonal anti-D BRAD-5. Vox Sang 2001 80 : 179 83.
25. Emsley J, Knight CG, Farndale RW, et al. Structural basis of collagen recognition by integrin alpha2beta1. Cell 2000 101 : 47 56.
26. Bordin JO, Kelton JG, Warner MN, et al. Maternal immunization to Gov system alloantigens on human platelets. Transfusion 1997 37 : 823 8.
27. Ertel K, Al Tawil M, Santoso S, et al. Relevance of the HPA-15 (Gov) polymorphism on CD109 in alloimmune thrombocytopenic syndromes. Transfusion 2005 45 : 366 73.
28. Joutsi-Korhonen L, Preston S, Smethurst PA, et al. The effect of recombinant IgG antibodies against the leucine-33 form of the platelet beta3 integrin (HPA-1a) on platelet function. Thromb Haemost 2004 91 : 743 54.
29. Proulx C, Chartrand P, Roy V, et al. Human monoclonal Fab fragments recovered from a combinatorial library bind specifically to the platelet HPA-1a alloantigen on glycoprotein IIb-IIIa. Vox Sang 1997 72 : 52 60.
30. Watkins NA, Schaffner-Reckinger E, Allen DL, et al. HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope. Blood 2002 99 : 1833 9.
31. Xiao T, Takagi J, Coller BS, et al. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004 432 : 59 67.
32. Kroll H, Penke G, Santoso S. Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a. Thromb Haemost 2005 94 : 1224 9.
33. Radder CM, Beekhuizen H, Kanhai HH, et al. Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells. Clin Exp Immunol 2004 137 : 216 22.
34. Kjeldsen-Kragh J, Killie M, Skogen B, Husebekk A. A screening and intervention program that significantly reduces mortality and serious morbidity associated with grave neonatal alloimmune thrombocytopenia. Vox Sang 2006 91 (Suppl 2 15.
35. Kiefel V, Bassler D, Kroll H, et al. Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood 2006 107 : 3761 3.
36. Engelfriet CP, Reesink HW, Kroll H, et al. Prenatal management of alloimmune thrombocytopenia of the fetus. Vox Sang 2003 84 : 142 9.
37. Radder CM, Brand A, Kanhai HH. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 2001 185 : 683 8.
38. Berkowitz RL, Kolb EA, McFarland JG, et al. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 2006 107 : 91 6.
39. Kanhai HH, van den Akker ES, Walther FJ, et al. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage. Fetal Diagn Ther 2006 21 : 55 60.
40. Armour KL, Clark MR, Hadley AG, et al. Recombinant human IgG molecules lacking Fcgamma receptor I binding and monocyte triggering activities. Eur J Immunol 1999 29 : 2613 24.
41. Armour KL, Parry-Jones DR, Beharry N, et al. Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity. Blood 2006 107 : 2619 26.